EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Decreased 5‐HT 1A binding in mild Alzheimer's disease—A positron emission tomography study

Patrik Mattsson iD, Zsolt Cselényi, Bengt Andrée, Jacqueline Borg, Sangram Nag, Christer Halldin, Lars Farde

Synapse · 2022-06 · 76 (7-8)

DOI: 10.1002/syn.22235 ↗

At a glance

Journal article in Synapse, published online on 2022-05-28. Written by Patrik Mattsson and 6 co-authors. Institution: Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County, Stockholm, Sweden. Major MEDLINE topics: Alzheimer Disease. Cited 16 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY 4.0). Funded by: Vetenskapsrådet.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Decreased 5‐HT 1A receptor binding has been associated with Alzheimer's disease (AD) and interpreted as a consequence of neuron loss. The purpose of the present study was to compare [ 11 C]WAY100635 binding to the 5‐HT 1A receptor in the hippocampus, entorhinal cortex, amygdala and pericalcarine cortex in mild AD patients and elderly controls. AD patients ( n = 7) and elderly control subjects ( n = 8) were examined with positron emission tomography (PET) and [ 11 C]WAY100635. PET data acquisition was performed with an ECAT EXACT HR system. Wavelet‐aided parametric images of nondisplaceable binding potential ( BP ND ) were generated using Logan's graphical analysis with cerebellum as the reference region. Correction for partial volume effects was performed with the Müller–Gärtner method. Regions of interest (ROIs) were applied to the individual parametric images, and the regional BP ND was calculated as the average parametric voxel value within each ROI. In addition to comparisons between subject groups, correlations between BP ND values and scores on the Mini‐Mental State Examination, Disability Assessment for Dementia (DAD), and Neuropsychiatric Inventory were expressed by Pearson correlation coefficients. Mean regional BP ND was lower in AD patients than in control subjects, and the difference was statistically significant for the hippocampus, entorhinal cortex, and amygdala. A statistically significant correlation was obtained between hippocampal BP ND values and DAD scores. The results of the present study corroborate and extend previous findings of decreased 5‐HT 1A binding in AD and strengthen the support for 5‐HT 1A receptor PET as a tool for the assessment of neurodegenerative changes in mild AD.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseAgedBrainEntorhinal CortexHumansPositron-Emission TomographyReceptor, Serotonin, 5-HT1ASerotonin

Author keywords

5-HT1A receptorAlzheimer's diseaseactivities of daily livingcognitive functionneurodegenerationpositron emission tomography

Substances

Receptor, Serotonin, 5-HT1ASerotonin

Authors and institutions

  • Department of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm County, Stockholm, Sweden.
  • Personalized Medicine, R&D, PET Science Centre, AstraZeneca, Stockholm, Sweden.

ORCID profiles: Patrik Mattsson

Funding

  • Vetenskapsrådet

Cite

APA

Mattsson, P., Cselényi, Z., Andrée, B., Borg, J., Nag, S., Halldin, C., & Farde, L. (2022). Decreased 5‐HT 1A binding in mild Alzheimer's disease—A positron emission tomography study. Synapse, 76(7-8). https://doi.org/10.1002/syn.22235

Vancouver

Mattsson P, Cselényi Z, Andrée B, Borg J, Nag S, Halldin C, et al. Decreased 5‐HT 1A binding in mild Alzheimer's disease—A positron emission tomography study. Synapse. 2022;76(7-8). doi:10.1002/syn.22235

BibTeX
@article{Mattsson2022,
  author = {Mattsson, Patrik and Cselényi, Zsolt and Andrée, Bengt and Borg, Jacqueline and Nag, Sangram and Halldin, Christer and Farde, Lars},
  title = {Decreased 5‐HT 1A binding in mild Alzheimer's disease—A positron emission tomography study},
  journal = {Synapse},
  year = {2022},
  volume = {76},
  number = {7-8},
  doi = {10.1002/syn.22235}
}
Start for free →